209 related articles for article (PubMed ID: 15961541)
1. Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts.
Nishikawa H; Kato T; Tawara I; Takemitsu T; Saito K; Wang L; Ikarashi Y; Wakasugi H; Nakayama T; Taniguchi M; Kuribayashi K; Old LJ; Shiku H
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9253-7. PubMed ID: 15961541
[TBL] [Abstract][Full Text] [Related]
2. Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells.
Nishikawa H; Kato T; Tawara I; Saito K; Ikeda H; Kuribayashi K; Allen PM; Schreiber RD; Sakaguchi S; Old LJ; Shiku H
J Exp Med; 2005 Mar; 201(5):681-6. PubMed ID: 15753203
[TBL] [Abstract][Full Text] [Related]
3. CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses.
Nishikawa H; Kato T; Tanida K; Hiasa A; Tawara I; Ikeda H; Ikarashi Y; Wakasugi H; Kronenberg M; Nakayama T; Taniguchi M; Kuribayashi K; Old LJ; Shiku H
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10902-6. PubMed ID: 12947044
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
5. BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD25- responder T cells than C57BL/6 mice.
Chen X; Oppenheim JJ; Howard OM
J Leukoc Biol; 2005 Jul; 78(1):114-21. PubMed ID: 15845645
[TBL] [Abstract][Full Text] [Related]
6. Activated CD1d-restricted natural killer T cells secrete IL-2: innate help for CD4+CD25+ regulatory T cells?
Jiang S; Game DS; Davies D; Lombardi G; Lechler RI
Eur J Immunol; 2005 Apr; 35(4):1193-200. PubMed ID: 15770696
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
[TBL] [Abstract][Full Text] [Related]
8. In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer.
Nagai H; Horikawa T; Hara I; Fukunaga A; Oniki S; Oka M; Nishigori C; Ichihashi M
Exp Dermatol; 2004 Oct; 13(10):613-20. PubMed ID: 15447721
[TBL] [Abstract][Full Text] [Related]
9. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
Fontenot JD; Gavin MA; Rudensky AY
Nat Immunol; 2003 Apr; 4(4):330-6. PubMed ID: 12612578
[TBL] [Abstract][Full Text] [Related]
10. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.
Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system.
Kipnis J; Mizrahi T; Hauben E; Shaked I; Shevach E; Schwartz M
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15620-5. PubMed ID: 12429857
[TBL] [Abstract][Full Text] [Related]
12. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.
Alard P; Manirarora JN; Parnell SA; Hudkins JL; Clark SL; Kosiewicz MM
Diabetes; 2006 Jul; 55(7):2098-105. PubMed ID: 16804081
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo.
Delgado M; Chorny A; Gonzalez-Rey E; Ganea D
J Leukoc Biol; 2005 Dec; 78(6):1327-38. PubMed ID: 16204628
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of interleukin-2 retards the growth of mouse renal cancer.
Fukuhara H; Matsumoto A; Kitamura T; Takeuchi T
BJU Int; 2006 Jun; 97(6):1314-21. PubMed ID: 16686731
[TBL] [Abstract][Full Text] [Related]
15. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
[TBL] [Abstract][Full Text] [Related]
16. Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent.
Valzasina B; Piconese S; Guiducci C; Colombo MP
Cancer Res; 2006 Apr; 66(8):4488-95. PubMed ID: 16618776
[TBL] [Abstract][Full Text] [Related]
17. Schistosoma japonicum egg antigens stimulate CD4 CD25 T cells and modulate airway inflammation in a murine model of asthma.
Yang J; Zhao J; Yang Y; Zhang L; Yang X; Zhu X; Ji M; Sun N; Su C
Immunology; 2007 Jan; 120(1):8-18. PubMed ID: 17042799
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of IL-12 and a novel negative feedback system mediated by CD25+CD4+ T cells.
Sato K; Tateishi S; Kubo K; Mimura T; Yamamoto K; Kanda H
Biochem Biophys Res Commun; 2005 Apr; 330(1):226-32. PubMed ID: 15781254
[TBL] [Abstract][Full Text] [Related]
19. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
Tulley JM; Palmer JL; Gamelli RL; Faunce DE
Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934
[TBL] [Abstract][Full Text] [Related]
20. CD25+ regulatory cells from HLA-DQ8 transgenic mice are capable of modulating collagen-induced arthritis.
Morgan ME; Witteveen HJ; Sutmuller RP; de Vries RR; Toes RE
Hum Immunol; 2004 Nov; 65(11):1319-27. PubMed ID: 15556682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
